PBM Definition & Meaning | Health Care Term | CSIMarket
CSI Market
Sign In | Register

Glossary

PBM

Health Care Term

Pharmacy Benefit Management (PBM) refers to the third-party administrators that manage drug plans for insurance companies, employers, and government entities. PBMs work with drug manufacturers, pharmacies, and insurers to reduce the cost of prescription medications and improve access to healthcare services.

The primary goal of PBMs is to control the cost of prescription drugs and improve prescription drug outcomes. They do this by negotiating drug prices, encouraging the use of generic medications, and implementing utilization management programs that promote more cost-effective drug use. PBMs also provide patient counseling, medication therapy management, and other clinical services to improve medication adherence and reduce healthcare costs.

PBMs play a critical role in the healthcare industry, especially in the United States, where prescription drug costs continue to rise. PBMs are responsible for administering prescription drug benefits for millions of people and negotiating prices with drug manufacturers to secure better deals. PBMs also provide oversight and monitoring of drug utilization to ensure that patients are using prescribed drugs safely and effectively.

Overall, PBM services are essential to the healthcare industry because they provide a cost-effective approach to managing prescription drugs while improving patient outcomes. PBMs help patients access the medications they need while keeping costs low, allowing patients to receive needed treatments without facing financial hardship.




More Glossary Terms Beginning with P
  • Paediatric Exclusivity
    means, in the US, a six-month period of exclusivity to market a drug which is awarded by the FDA in return for certain paediatric clinical studies using that drug. This six-month period runs from the date of relevant patent expiry.
    Health Care Term Letter: P
  • Paid Development Method
    An actuarial method to estimate ultimate losses for a given cohort of claims such as an accident year/product line component. If the paid-to-date losses are then subtracted from the estimated ultimate losses, the result is an indication of the unpaid losses. The basic premise of the method is that cumulative paid losses for a given cohort of claims will grow in a stable, predictable pattern from y
    Insurance Term Letter: P
  • Panelboards
    Oriented strand board, particleboard, medium density fibreboard and plywood. Operating Statistics
    Manufacturing Term Letter: P
  • Partial Remission PR
    A decrease in the size of a tumor, or in the extent of cancer in the body, in response to treatment.
    Health Care Term Letter: P
  • Particleboard
    A panelboard produced by chemically bonding clean sawdust, small wood particles and recycled wood fibre under heat and pressure. Forestry & Wood Products Industry Operating Statistics
    Manufacturing Term Letter: P
  • Particulate Matter
    Total suspended particulate. A measure of the solid particles (wood, process dust and smoke) found in air emissions.
    Manufacturing Term Letter: P
  • Particulates
    Tiny particles of a substance.
    Manufacturing Term Letter: P
  • Passenger Load Factor
    Represents the total number of seats sold as a percentage of total seat capacity on all sectors flown. Airline Industry
    Transportation Term Letter: P
  • Passenger Mile Yield
    The amount of passenger revenue earned per revenue passenger mile during a reporting period Airline Industry
    Transportation Term Letter: P
  • Passenger revenue yield per Mile Average Yield per RPM
    Represents the average scheduled passenger fare revenue for each revenue passenger mile (RPM), or each mile a scheduled revenue passenger is flown. Airline Industry
    Transportation Term Letter: P
  • Passive Immunotherapy
    Immunologically active material transferred into the patient as a passive recipient. Monoclonal antibodies are considered Passive Immunotherapy since antibodies are generated outside the body and given to the patient
    Health Care Term Letter: P
  • Patent Term Extension
    means an extension of up to five years in the term of a US patent relating to a drug which compensates for delays in marketing resulting from the need to obtain FDA approval.
    Health Care Term Letter: P